Effects of Tamoxifen on Mitochondrial NOS activity: alteration in the intramitochondrial Ca2+ homeostasis by Joshi, Sandeep S.
Marshall University
Marshall Digital Scholar
Theses, Dissertations and Capstones
1-1-2005
Effects of Tamoxifen on Mitochondrial NOS
activity: alteration in the intramitochondrial Ca2+
homeostasis
Sandeep S. Joshi
Follow this and additional works at: http://mds.marshall.edu/etd
Part of the Medical Toxicology Commons, and the Oncology Commons
This Thesis is brought to you for free and open access by Marshall Digital Scholar. It has been accepted for inclusion in Theses, Dissertations and
Capstones by an authorized administrator of Marshall Digital Scholar. For more information, please contact zhangj@marshall.edu.
Recommended Citation
Joshi, Sandeep S., "Effects of Tamoxifen on Mitochondrial NOS activity: alteration in the intramitochondrial Ca2+ homeostasis"
(2005). Theses, Dissertations and Capstones. Paper 678.
Effects of Tamoxifen on Mitochondrial NOS activity: alteration in the 
intramitochondrial Ca2+ homeostasis 
 
Thesis submitted to 
The Graduate College of 
Marshall University 
 
 
 
 
In partial fulfillment of the  
Requirements for the degree of 
Master of Science  
Biological Sciences 
by 
 
Sandeep S. Joshi 
 
Dr. Eric Blough, Committee Chairperson 
Dr. Pedram Ghafourifar 
Dr. Simon Collier 
 
 
 
Marshall University 
 
 
 
 
04/25/2005 
 
Key words: Tamoxifen, mtNOS, mitochondria, nitric oxide, calcium, transmembrane 
potential. 
Sandeep S. Joshi 
 
ABSTRACT 
Effects of Tamoxifen on Mitochondrial NOS activity: alteration in the 
intramitochondrial Ca2+ homeostasis 
Sandeep S. Joshi 
Tamoxifen (Tam) is an anticancer drug that induces oxidative stress and apoptosis via 
mitochondria- and nitric oxide (NO)-dependent pathways. Here, we report that 
therapeutic concentrations of Tam stimulate the mitochondrial NO synthase (mtNOS) 
activity of isolated rat liver mitochondria by increasing the intramitochondrial ionized 
Ca2+ concentration ([Ca2+]m). Tam decreases transmembrane potential (∆ψ) due to 
increased [Ca2+]m that neutralizes the negative charges of the inner mitochondrial 
membrane. Thus, the present study reports a novel mechanism for the widely used anti-
caner drug, Tam. 
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CHAPTER I 
 
Introduction 
 
Tamoxifen (Tam) is the prototype of a drug family known as estrogen receptor (ER) 
modulators. Although Tam was originally introduced as an ER antagonist, subsequent 
studies have shown agonistic activity of Tam in various biological models (Osborne 
2000;Graham 2000; Graumann 2000). Many cancer chemotherapeutic agents (Grad 
2001) including Tam (Dietze 2001) exert their anti-cancer properties by inducing 
apoptotic cell death through mechanisms that involve mitochondria. Therapeutic doses of 
Tam are 150-300 µg. day-1. Kg-1 body weight with an average therapeutic blood 
concentration of 120 ng/ml that is equal to 0.3 nmol/ml (Thummel 2001). Treatment of 
isolated rat liver mitochondria with 20-100 nmol/ml Tam, concentrations 60 to 300 times 
greater than the therapeutic, inhibited mitochondrial permeability transition pore opening 
(Custodio 1998). Likewise, these high concentrations of Tam increased the mitochondrial 
respiration and proton permeability, and decreased transmembrane potential (∆ψ) and 
oxidative phosphorylation (Tuquet 2000; Cardoso 2001) that are typical of uncoupling 
mitochondria. In the present study the effect of therapeutic concentrations of Tam on 
isolated rat liver mitochondria has been tested. 
Tam induces apoptosis in both ER-positive and -negative cells via nitric 
oxide (NO)-dependent pathways (Loo 1998; Maccarone 1998). Tam increased the NO 
synthase (NOS) activity in 10T1/2 murine fibroblasts (Loo 1998) and in human 
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erythroleukemia K562 cells undergoing apoptosis induced by Tam (Maccarone 1998). 
Moreover, exogenous addition of NO potentiated the Tam-induced apoptosis and 
inhibition of NOS activity prevented the apoptosis induced by Tam (Maccarone 1998). 
We have shown that mitochondria possess a Ca2+-sensitive NOS 
(mitochondrial NOS; mtNOS) (Ghafourifar 1997). NO generated by mtNOS regulates 
mitochondrial bioenergetics by reversible regulation of cytochrome c oxidase activity 
(Ghafourifar 1997; Ghafourifar 1999e). mtNOS-derived NO also reacts with superoxide 
anion (O2-) to generate peroxynitrite that induces oxidative stress and apoptosis 
(Ghafourifar 1999e). In the present study we tested the effect of Tam on mtNOS. We 
demonstrate that Tam stimulates the mtNOS activity of isolated rat liver mitochondria via 
increasing intramitochondrial ionized Ca2+ concentration ([Ca2+]m), and decreases the 
transmembrane potential (∆ψ). 
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CHAPTER II 
 
Review of Literature 
 
Tamoxifen 
Tam is an estrogen receptor (ER) antagonist widely used in the treatment of breast 
cancer, the second most common cause of death due to cancer in women. Although Tam 
is known for exerting ER antagonist properties, few studies have shown ER  agonistic 
properties in different biological models (Osborne 2000;Graham 2000; Graumann 2000). 
Tam induces programmed cell death, or apoptosis, in both ER positive and ER negative 
cells; however, its mechanism of action is not fully understood. Many cancer 
chemotherapeutic agents (Grad 2001) including Tam (Dietze 2001) exert their anti-cancer 
properties by inducing apoptotic cell death through mechanisms that involve 
mitochondria. The therapeutic doses for Tam are 150-300 µg. day-1. Kg-1 body weight 
with an average therapeutic blood concentration of 120 ng/ml that is equal to 0.3 nmol/ml 
(Thummel 2001). It has been shown that high concentrations of Tam increased the 
mitochondrial respiration and proton permeability, decreased transmembrane potential 
(∆ψ) and oxidative phosphorylation (Tuquet 2000; Cardoso 2001), that are typical of 
uncoupling mitochondria by highly lipophilic compounds, such as Tam. 
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Mitochondria 
Mitochondria are lipoprotein particles of characteristic shape, size and structure. They are 
present in the cytoplasm of all eukaryotic cells of higher animals and plants, and also in 
certain microorganisms. The physiological role of the mitochondrion is based on two 
themes in biological research. First, the systematic study of their structure, function, and 
behavior in living cells and second the study of the mechanism of intracellular 
respiration. The application of this knowledge is helping us understand the integrated 
behavior of mitochondria in living cells, as well as providing new concepts of medical 
significance in the fields of mitochondrial diseases, cancer, and the aging process (Tyler 
1992). 
 
 
NO and NOS 
Nitric oxide (NO) is a gas at temperatures above –152°C. It is slightly soluble in many 
solvents and can diffuse relatively easily across biological membranes. The pioneering 
discovery of Moncada (Palmer et al., 1987) that endothelium-derived relaxing factor is 
NO has changed the view of NO as a toxic gas to a very important factor in biology 
(Koshland, 1992). NO synthase (NOS; EC 1.14.13.39) isozymes synthesize NO from L-
arginine.  This reaction is a two-step, five-electron oxidation of the terminal guanidino 
nitrogen of L-arginine with N-hydroxy-L-arginine as the intermediate.  In this reaction, 
O2 is consumed stoichiometrically and produces L-citrulline as the final co-product. 
Endothelial (eNOS), neuronal (nNOS), and inducible NOS (iNOS) are three distinct 
isoforms of NOS generally found in mammalian tissues. nNOS and eNOS are typical 
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Ca2+/calmodulin-sensitive enzymes. However, iNOS forms a tight complex with 
calmodulin at very low Ca2+ concentrations and alterations in cellular Ca2+ status do not 
alter iNOS activity (Moncada 1991). 
NO plays crucial functions in various biological systems (Reviewed in 
Moncada et al., 1991).  For example, NO maintains the blood pressure low and prevents 
platelet aggregation and adhesion. NO is a neurotransmitter for functions including 
memory formation in central nervous system.  In the peripheral nervous system, NO is 
the modulator of nociception at the spinal cord and mediates the nonadrenergic and 
noncholinergic neurotransmission.  
Biological targets of NO include hemoproteins, thiols, and superoxide 
anion (O2-).  Mitochondria contain several hemoproteins and thiol containing molecules, 
and they are one of the prime cellular producers of O2-.  Thus, mitochondria remain one 
of the main biological targets for NO (Ghafourifar and Colton 2003).  NO reacts with 
these mitochondria targets in distinct manners (Scheme 1). NO reversibly inhibits 
cytochrome c oxidase, the terminal enzyme of the respiratory chain that is an abundant 
mitochondrial hemoprotein embedded in mitochondrial inner membrane, and decrease O2 
consumption in a manner that resembles a pharmacological competitive antagonism 
between NO and O2 (Ghafourifar 2000). NO can react with a reduced thiol to produce a 
nitrosothiol. Several mitochondrial apoptogenic proteins that contain thiols including 
caspase-3 are located within mitochondrial intermembrane space.  NO reacts with a free 
thiol on caspase-3 to produce S-nitrosated caspase-3 that is apoptotically silent.  This 
anti-apoptotic property of NO protects the organelles against the proteolytic activity of 
the caspase and cells against apoptosis (Reviewed in Ghafourifar 2003).  
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NO reacts with O2- with the nearly diffusion-controlled rate constant of 1.9 
x 1010 M s-1 (Kissner 1997).  This reaction leads to the formation of peroxynitrite, a 
highly reactive NO-derived species.  This reaction is preferred in the matrix fraction of 
mitochondria (Ghafourifar 2003).  Peroxynitrite causes oxidative damage to various 
mitochondrial respiratory chain components (Sharpe 1998; Ghafourifar 1999d; Riobo 
2001, Reviewed in Szibor 2001), inactivates mitochondrial matrix enzymes such as 
manganese superoxide dismutase (MnSOD; MacMillan-Crow 1998) and succinyl-
CoA:3-oxoacid CoA-transferase (SCOT; Turko 2001), and releases cytochrome c from 
the mitochondria (Ghafourifar 1999e).  Inactivation of MnSOD and SCOT are involved 
in oxidative stress, and release of cytochrome c from the mitochondria is one of the key 
events during apoptosis in many cells.  
 
 
mtNOS 
 During the period of 1995 and 1996 the presence of a NOS-like protein within 
mitochondria was suggested by some immunohistochemical studies (Bates 1995, 1996; 
Kobzik 1995; Frandsen 1996;).  In 1997, the first report on the existence of a 
constitutively expressed and continuously active NOS in mitochondria (mitochondrial 
NOS; mtNOS), the association of mtNOS with the mitochondrial inner membrane, and 
determination of mtNOS activity was published (Ghafourifar 1997).  It was also shown 
that mtNOS is Ca2+-dependent and its activity increases with elevation of 
intramitochondrial Ca2+ ([Ca2+]m), and that mtNOS exerts substantial control over 
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mitochondrial respiration and transmembrane potential (∆ψ). Soon thereafter these 
findings were confirmed by several other investigators (Reviewed in Ghafourifar 2005). 
mtNOS-derived NO decreases O2 consumption, ∆ψ and mitochondrial 
matrix pH by inhibiting cytochrome c oxidase activity (Ghafourifar 1997; Ghafourifar 
1999e,c).  Inhibition of the basal endogenous mtNOS activity increases basal 
mitochondrial O2 consumption and ∆ψ (Ghafourifar 1997), causes mitochondrial matrix 
alkalinization, and provides a resistance to the sudden drop of ∆ψ induced by elevation of 
[Ca2+]m (Ghafourifar 1999c,e).  These findings suggest that mtNOS is continuously active 
and reversibly regulates mitochondrial respiration and respiration-dependent functions. 
mtNOS also exerts a feed-back regulatory function that protects mitochondria against 
Ca2+ overload.  Increased [Ca2+]m stimulates mtNOS-derived NO formation (Ghafourifar 
1997, 1999e, Kanai 2001; Dedkova 2003; Lores-Arnaiz 2004) that causes Ca2+ efflux 
from the mitochondria via at least 2 pathways: a) directly increase Ca2+ efflux from 
mitochondria by decreasing ∆ψ, or b) reacting with O2- to produce ONOO-, which then 
stimulates the specific mitochondrial Ca2+ release pathway with preserved ∆ψ. The latter 
mechanism involves oxidation of mitochondrial pyridine nucleotides (Bringold 2000).   
 
 
 Mitochondria, NO and apoptosis 
Apoptosis, also called programmed cell death, is an evolutionarily conserved mechanism 
required for normal cell and tissue homeostasis (Kerr 1972).  Aberrant apoptosis is one of 
the prime pathological mechanisms underlying numerous diseases including cancer, 
ischemia/reperfusion-induced cardiac injury, and neurodegenerative diseases.  
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Mitochondria play a key role in apoptosis (Green 1998; Ghafourifar 2000).  Interaction 
with mitochondria is one of the early events in apoptosis induced by many apoptogenic 
factors including NO and peroxynitrite.  Mitochondria possess key pro- and anti-
apoptotic proteins such as Bax, caspases, and Bcl-2.  Moreover, release of cytochrome c 
is one of the most crucial apoptosis triggers in many cells.  Accordingly, mitochondria 
are called the “switchboard of apoptosis” (Ghafourifar 2001; Szibor 2001).   
A substantial number of recent reports indicate that NO induces apoptosis 
through mechanisms that involve formation of peroxynitrite (Leist 1997; Keller 1998; 
Ferrante 1999).  This form of apoptosis occurs with mitochondrial dysfunction and 
perturbed mitochondrial redox balance (Almeida 1998; Keller 1998).  NO reacts with O2- 
to produce peroxynitrite with the nearly diffusion-controlled rate of 1.9 x 1010 M s-1 
(Kissner 1997).  NO and O2- are produced in a close vicinity within mitochondria: O2- is 
produced at the inner membrane during electron transfer, and NO is produced by the 
inner membrane associated mtNOS.  Thus, it is very conceivable that mtNOS-derived 
NO forms peroxynitrite.  Several groups have reported that mtNOS, indeed, generates 
peroxynitrite (Ghafourifar 1999e; Poderoso 1999; Bringold 2000; Cadenas 2001; Boveris 
2002; Alvarez 2003; Kanai 2004; Dedkova 2003; Navaro 2004) and that a substantial 
amount of NO produced within mitochondria converts to peroxynitrite (Lacza 2001; 
Kanai 2004, Dedkova 2003).  The first report on the generation of peroxynitrite by 
mtNOS demonstrated that mtNOS-derived peroxynitrite induced oxidative stress and 
released cytochrome c from the mitochondria in a manner prevented by the anti-apoptotic 
protein Bcl-2 (Ghafourifar 1999e).  Boveris et al. (2002) have shown that mtNOS-
derived peroxynitrite induces mitochondrial dysfunction and contractile failure in rat and 
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human skeletal muscle.  A role for mtNOS-derived peroxynitrite in apoptotic cell death 
of SH-SY5Y neurons has also been reported (Dennis 2003).  
 
 
Determination of mtNOS activity 
Most of the mtNOS studies have been conducted using isolated mitochondria. Isolated 
mitochondria maintain most of their features as within cells, yet numerous confounding 
factors that limit studying these organelles in cells or tissues are avoided. The following 
are the commonly used mtNOS assays, namely photometry, amperometry, and 
radioassay.  
Oxyhemoglobin assay 
Spectrohpotometery has been widely used to measure mtNOS activity using the 
oxyhemoglobin (oxyHb) assay. NO stoichiometrically reacts with oxyHb to produce 
methemoglobin (metHb). Mitochondria contain all the substrate and co-factors that 
mtNOS requires, and elevation of [Ca2+]m per se is sufficient to stimulate mtNOS activity 
in intact mitochondria (Ghafourifar 1997; 1999e).  However, dilution or oxidation of 
some of the mtNOS substrates or cofactors during the preparation of broken mitochondria 
(BM) or submitochondrial particles (SMP) may require the presence of the additonal 
substrates or cofactors in mtNOS assay medium. In dual-wavelengths spectroscopy, 
measurements at 401-420 nm with ε401-420 (metHb-oxyHb) 100 mM-1 cm-1 provides a very 
sensitive measurement.  
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Fluoro-photometric determination of mtNOS activity 
Some laboratories have used fluoro-photometric NO probes such as 4,5-diamino-
fluorescein diacetate (DAF-2-DA) and detected mtNOS activity in a variety of cells 
(Dennis 2003; Lacza 2003; Dedkova 2003). 
 
 Amperometric mtNOS assay 
Clark-type electrodes have been widely used to determine NOS activity.  These 
electrodes are relatively easy to use, do not require handling radioactive material or rather 
sophisticated dual-beam spectroscopy, and they are sensitive enough for most practical 
purposes. Several NO-sensitive electrodes that are commercially available perform under 
the same principle: NO diffuses through a semi-permeable membrane and reaches the tip 
of the working electrode where it becomes oxidized by the electrode to NO3. The 
commercially available NO sensors can be used to measure mtNOS activity 
 
mtNOS activity radioassay 
Determination of radiolabeled L-citrulline produced from radiolabeled L-arginine is a 
widely used NOS assay also used for NOS activity determination.  To measure mtNOS 
activity in intact mitochondria, the citrulline assay is preferred over oxyHb assay 
(Ghafourifar 2005). 
 
 
[Ca2+]m determination 
Measured by dual-wavelengths spectroscopy, Ca2+- sensitive electrode and fluorometry. 
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Spectroscopy: 
The Ca2+- sensitive probe Arsenazo III is used to detect [Ca2+]m at 675-685 nm. To allow 
[Ca2+]m to equilibrate with extramitochondrial buffer where the Arsenazo III probe is 
present, ∆ψ has to be collapsed. A Calibration curve can be obtained by using known 
concentrations of Ca2+. 
 
Calcium electrode: 
Mitochondria are placed in the Ca2+-sensitive electrode chamber and ∆ψ is collapsed to 
allow intramitochondrial Ca2+ equilibrate with extramitochondrial buffer. Calibration 
curve is obtained by known concentrations of Ca2+. 
Both methods and particularly the dual-wavelength spectroscopy are 
extremely sensitive.  A limitation is that both assays measure [Ca2+]m only after it has 
equiliberated with extramitochondria. Recently, we established in our lab a fluorescent 
assay (discussed below) that is an excellent alternative and a complementary assay to 
dual-wavelengths spectroscopy and Ca2+-electrode. This study has used this assay to 
measure [Ca2+]m inside the mitochondria. 
 
Fluorometery:  
The membrane permeable fluorescent Ca2+ probe Fura-2/acetoxymethylester (Fura-
2/AM) has been widely used to measure [Ca2+]m (Lukacs 1987; McCormack 1989; 
Zottini 1993; Zaidan 1994).  In mitochondria, Fura-2/AM is cleaved to the membrane 
impermeable Fura-2 that is the active Ca2+-sensitive fluorescent probe (Zottini 1993; 
Sandeep S. Joshi 
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Zaidan 1994).  Fura-2/AM loaded intact mitochondria can be studied to measure the 
[Ca2+]m using excitation wavelengths of 352-362 nm and emission of 510 nm.  
 
 
Tam and Ca2+- sensitive mtNOS 
Tam increased the NO synthase (NOS) activity in 10T1/2 murine fibroblasts (Loo 1998) 
and in human erythroleukemia K562 cells undergoing apoptosis induced by Tam 
(Maccarone 1998). Moreover, exogenous addition of NO potentiated the Tam-induced 
apoptosis and inhibition of NOS activity prevented the apoptosis induced by Tam 
(Maccarone 1998). Tam-induced apoptosis occurs in a NOS- and mitochondria-
dependent manner along with suppressed mitochondrial functions and oxidative stress. 
The present study conducted in our laboratory suggests a crucial role for mtNOS in the 
apoptogenic properties of Tam. The study proposes a novel mechanism for Tam that is 
stimulating mitochondrial nitric oxide synthase (mtNOS) activity by increasing the 
intramitochondrial ionized calcium concentration. 
Sandeep S.Joshi 
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CHAPTER III 
 
Methods 
 
Chemicals 
Mannitol, HEPES, EDTA, hemoglobin, dithionite, Na-nitrite, SOD,         tamoxifen ([Z]-
1-[p-Dimethylaminoethoxyphenyl]-1,2-diphenyl-1-butene), EGTA, rotenone, safranin, 
carbonyl cyanide m-chlorophenylhydrazone (CCCP), carbonylcyanide-4-
trifluoromethoxyphenylhydrazone (FCCP), Na-cholate, BSA and CuSO4 were purchased 
from Sigma-Aldrich (St. Louis, MO), sucrose, CaCl2 were purchased from Fisher 
Scientific (Fair Lawn, NJ), liquid nitrogen was purchased from Mountain State Air 
gas(Huntington, WV), L-arginine, succinate (succ), NaOH, KOH were purchased from 
Fluka (Buchs, Switzerland), N
ω
-monomethyl-L-arginine (L-NMMA), Fura-2 
pentapotassium salt active form (Fura-2) were purchased from Alexis (San Diego, CA ), 
Ethanol was purchased from Aaper (Shelbyville, KY), Fura-2/acetoxymethylester (Fura-
2/AM) was purchased from Calbiochem (La Jolla, CA). 
 
 
Isolation of mitochondria and preparation of mitochondrial subfraction 
Liver mitochondria were purified from female Sprague-Dawley rats (180-220g). The rats 
were fasted overnight with access to water ad libitum. Euthanasia was performed by 
decapitating and depleting the body of blood to limit exposure of mitochondria to NO 
reacting molecules including hemoglobin. The liver was removed and kept in a dish on 
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ice, and fat, ducts, vessels, connective tissues and blood clots were removed. The liver 
was cut into small pieces and washed several times in ice-cold buffer containing mannitol 
(210 mM) sucrose (70 mM) HEPES (5 mM) / EDTA (1 mM) pH 7.40 (MSH/EDTA) to 
remove the remaining blood. Homogenization was performed in 60 ml of MSH/EDTA. 
Care was taken to keep the temperature low and to avoid unnecessary mechanical force 
during the homogenization, because they can damage mitochondria and mtNOS 
(Ghafourifar 2005). The homogenate was spun at 1,000 x g for 10 min. The supernatant 
was collected and spun at 10,000 x g for 10 min. The floating coat of fat on top was 
removed by soft tissue and then the supernatant was discarded. The pellet was 
resuspended with “cold finger” in 40 ml MSH. The suspension was spun at 1,000 x g for 
5 min, and the supernatant was spun at 10,000 x g for 10 min. The pellet was resuspended 
in MSH buffer, spun at 10,000 x g for 10 min. The pellet that is the enriched 
mitochondria fraction was resuspended in 1ml of MSH buffer, and stored on ice. The 
protein content was determined by the Biuret assay. 
 
Biuret assay:  
Blank:  Twice 500 µl H2O 
Standard: Twice 450/400/300 µl H2O and 50/100/200 µl BSA 
Sample: Twice 10 µl mitochondria and 490 µl H2O 
Added to all test tubes: 200 µl Na-Cholate (4% w/v in H2O) 
     2 ml 10% NaOH 
     300 µl CuSO4 
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Tubes were incubated at room temperature for 20 min and the absorbance was measured 
at 540 nm. The mitochondrial protein content was computed by standard curve method. 
   The purity of the mitochondrial preparation was assessed by measuring the 
cytochrome a content performed spectrophotometrically. The OD of a mitochondrial 
suspension (1 mg/ml) was measured at 605-630 before and after reduction with dithionite 
and the cytochrome a concentration was calculated using ε605-630nm 12 mM-1 cm-1. Only 
mitochondria with less than 5% impurity were used in this study.  
 
Preparation of Broken Mitochondria:  
Broken mitochondria were prepared from freshly isolated intact mitochondria by freeze-
thawing in liquid Nitrogen three times for 3 min each (Ghafourifar 1997; Ghafourifar 
1999e). 
 
 
Preparation of Stock Solutions 
 
Tamoxifen: 
Tam was dissolved in ethanol. The spectrum of Tam is shown in Fig. 1. The 
concentration of Tam was determined by using ε270 nm 13 mM-1 cm-1.  The stock solutions 
were prepared at 1,000 x and stored at –80 oC.  
 
Oxyhemoglobin: 
Bovine hemoglobin was dissolved in HEPES buffer (100 mM pH 7.10). It was fully 
reduced to oxyhemoglobin (oxyHb) with dithionite, and the excess dithionite was 
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removed by purifying the oxyHb using column purification (G-25 Sephadex columns). 
The spectrum of oxyHb is shown in Fig. 2. The concentration of the purified oxyHb was 
measured by using ε415 nm 131 mM-1 cm-1.  Stored at –80 °C after aliquotizing.  
 
 
General incubation procedure  
 Unless mentioned otherwise, mitochondria samples were prepared by incubating 
mitochondria or mitochondrial subfraction (1 mg protein) in 100 µl HEPES buffer (100 
mM pH 7.10) in the presence or absence of 100 µM L-NMMA (to inhibit mtNOS; Refs 
Ghafourifar 2002; Ghafourifar 2005) for 30 min on ice. Tam (0.1 or 0.3 µM) or equal 
volume of its solvent (ethanol) was added and mitochondria were incubated for 20 min at 
room temperature, with occasional gentle shaking.  
 
 
Oxyhemoglobin assay 
NO stoichiometrically reacts with oxyHb to produce methemoglobin (metHb).  
The conversion of oxyHb (10 µM in 100 mM HEPES pH 7.10 at 23 oC) to metHb by 
addition of a NO releasing compound Na-Nitrite was recorded from 380 to 680 nm using 
an Aminco DW-2000 spectrophotometer (see in Results and Discussion). 
 
Determination of mtNOS activity by using oxyHb assay:  
mtNOS produces NO that converts oxyHb to metHb. To use oxyHb assay to measure 
mtNOS activity of broken mitochondria, the following substrates or cofactors were 
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present in the medium: 100 µM Ca2+ (100 mM stock solution was prepared, aliquotized 
and stored at –20 °C), 100 µM L-arginine (100 mM stock solution was prepared and 
stored at –20°C. Frequent freeze-thawing was avoided), 1 KU/ml SOD (300 KU/ml stock 
solution was prepared.  Aliquotized and stored at –20 °C.  Frequent freeze-thawing was 
avoided). 
mtNOS activity of rat liver broken mitochondria (0.03 mg/ml) was 
determined at 401-420 nm using a dual-beam dual-wavelengths Aminco-DW-2000. To 
the HEPES buffer (100 mM pH 7.10) containing L-arg  and SOD, rat liver broken 
mitochondria (with or without incubating with L-NMMA as per General incubation 
procedure) was added. After a steady reading was achieved, oxyHb (4 µM) was added 
and the formation of metHb was recorded for 2.5 min. To stimulate mtNOS activity, Ca2+ 
(100 µM) was present in the buffer prior to the addition of oxyHb.  
 
Tam and mtNOS activity: 
To test the effect of Tam on mtNOS activity, 0.03 mg/ml broken mitochondria were 
incubated with Tam (Tam 0.1 and 0.3 µM) or ethanol (Cont) in presence or absence of L-
NMMA as described in General incubation procedure. These mitochondria preparations 
were added to the HEPES buffer (100 mM pH 7.10) and mtNOS activity was determined 
at 401-420 nm. The mtNOS activity was calculated as below, and expressed as nmol/mg 
mitochondria. 
Consider, 
Difference in OD of sample and autoxidation of oxyHb = ∆OD 
OD at 2.5 min for autoxidation of oxyHb = A 
Sandeep S. Joshi 
 18
OD before the addition of oxyHb for autoxidation of oxyHb = B 
OD at 2.5 min in sample = C 
OD before the addition oxyHb in sample = D 
Calculate ?   ∆OD = (D – C) – (B – A). 
   Then NO release (nmol/mg mitochondria) was calculated by using ε401-420 
nm 100 mM-1 cm-1. 
 
 
Fluorometeric determination of [Ca2+]m  
In our laboratory, we developed an assay that allows using fluorometery to detect 
intramitochondrial [Ca2+]m. Since excited Fura 2 emits at 510 nm, the Aminco DW-2000 
Original Fluorescent Accesory Unit was equipped with a precision 510 ± 5 nm Bandpass 
Filter (Edmund Industrial Optics, Barrington, NJ; Knox 2003) (Fig. 3). To test and 
validate this setup, and to determine the peak and isosbestic points, Fura-2 (the active 
form; 10 µM) in the absence (no Ca2+) or presence of 1, 3, 10 and 30 µM Ca2+ in a final 
volume of 2 ml HEPES buffer (100 mM pH 7.10) was excited from 320 to 400 nm and 
the emission was recorded at 510 nm. A peak and an isosbestic point were found at 352 
and 362 nm, repectively (see in Results and Discussion) 
 
Fura-2/AM mitochondria incubation procedure:  
The membrane permeable fluorescent Ca2+ probe Fura-2/AM has been widely used to 
measure [Ca2+]m (Lukacs 1987; Zottini 1993; Zaidan 1994). In mitochondria, Fura-2/AM 
is cleaved by esterases to the membrane impermeable Fura-2 that is the active Ca2+-
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sensitive fluorescent probe (Zottini 1993; Zaidan 1994). Rat liver intact mitochondria 
were incubated with Fura-2/AM with a ratio of mitochondria to Fura-2 : 1 mg to 4 nmol 
in 1 ml of MSH buffer pH 7.40 for 30 min at room temperature with gentle shaking. The 
Fura-2/AM loaded mitochondria samples were then washed twice with cold MSH and 
spun at 10,000 x g for 3 min at 4 oC. To find the peak and isosbestic points, Fura-2/AM 
loaded intact mitochondria were loaded with 1, 3, 10, 30 and 100 µM Ca2+ in a final 
volume of 2 ml HEPES buffer (100 mM pH 7.10). These mitochondria were excited from 
320 to 400 nm and the emission was recorded at 510 nm. A dose-dependent increase in 
fluorescence was observed with the same peak and isosbestic points, i.e., 352, 362 nm. 
Next, Fura-2/AM loaded mitochondria were excited at 352-362 nm and the emission was 
recorded at 510 nm. A dose-dependent increase in fluorescence was obtained in the 
absence (no Ca2+) or presence of 1, 3, 10, and 30 µM Ca2+. 
 
Tam and intramitochondrial [Ca2+]m: 
Fura-2/AM loaded intact mitochondria (2 mg) in a final volume of 2 ml HEPES buffer 
(100 mM pH 7.10) were used to study the effect of Tam on [Ca2+]m. To chelate the traces 
of Ca2+ contamination that we found in our buffers, EGTA (50 µM) was added into the 
buffer prior to addition of mitochondria. To prevent ∆ψ drop due to elevated [Ca2+]m, 
Fura-2/AM loaded mitochondria were energized with Succ [300 µM in the presence of 
rotenone (5 µM)] to maintain the ∆ψ. These mitochondria were treated with Tam (Tam 
0.1 and 0.3 µM) or ethanol (Cont) used as solvent. After 4 min, Ca2+ (10 µM) was added 
to provide a scale for quantification. At the end of the test, ∆ψ was collapsed by the 
uncoupler FCCP (5 µM) to validate the assay.  
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∆ψ: 
Purified intact rat liver mitochondria (2 mg/ml) in a final volume of 2 ml HEPES buffer 
(100 mM pH 7.10) containing EGTA (50 µM) was used to test whether 300 µM succ 
maintains the ∆ψ . Mitochondria were energized with succ (300 µM) in the presence of 
rotenone (2.5 µM), and Ca2+ (10 µM) was added. The ∆ψ was measured by dual-
wavelengths spectroscopy at 511 – 533 nm using safranin (10 µM) as described (Manzo-
Avalos 2002; Boveris 2003; Figtree 2000).  At the end of the test, ∆ψ was collapsed by 
FCCP (5 µM).  
 
Tam and ∆ψ 
The ∆ψ of intact mitochondria treated with Tam (Tam 0.1 µM) or ethanol (Cont) was 
supported by succ (0.8 mM) and measured at 511 – 533 nm in the presence of safranin 
(10 µM) using an Aminco DW-2000 spectrophotometer as described (13, 17). At the end 
of the test, ∆ψ was collapsed by CCCP (5 µM).  
 
Statistical analysis 
Each experiment was repeated at least 4 times. The mean and standard deviation was 
calculated. The unpaired Student’s T-test was conducted. P < 0.05 was considered 
significant. 
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CHAPTER IV 
 
Results and Discussion 
 
 
Apoptosis is a fundamental mechanism that regulates cell and tissue homeostasis and 
eliminates cancer cells (Kerr 1972). It is generally believed that cancer is caused because 
some cells fail to undergo apoptosis (Sjostrom 2001). The chemotherapeutic agents used 
in cancer treatment (Grad 2000) including Tam (Dietze 2001, Mandlekar 2001) induce 
oxidative stress and apoptosis via mechanisms that involve mitochondria and NO (Loo 
1998, Maccarone 1998). We (Ghafourifar 1997) and several other laboratories (Arnaiz 
1999; Manzo-Avalos 2002; Boveris 2003; Kanai 2001; Alvarez 2003; Dedkova 2003 
Reviewed in Ref. Ghafourifar 2005) have shown that mitochondria generate NO through 
a Ca2+-sensitive mitochondrial NOS, the mtNOS. We have also shown that stimulation of 
mtNOS by elevating [Ca2+]m leads to the formation of peroxynitrite that induces oxidative 
stress and mitochondrial apoptosis (Ghafourifar 1999e). In the present study we 
investigated the effect of Tam on mtNOS activity. 
 
 
Tam increases mtNOS activity 
NO produced by mtNOS reacts with oxyHb to produce metHb in a stoichiometric manner 
(equation 1).  
Equation 1: oxyHb + NO  ?  metHb + NO3- 
Fig. 4 shows distinct optical behaviors of these species, i.e., oxyHb converted to metHb 
by NO. The superimposed individual absorbtion spectra of oxyHb and metHb showed 
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peaks at 415.2, 541.8, and 577.6 nm for oxyHb and 406.8 nm for metHb and intersection 
points represent those wavelengths at which the absolute absorbances of either species 
remains unchanged at 471.4, 525.6 and 590.4 nm. These points are called isosbestic 
points, thus the absorbance at these points does not change during conversion of oxyHb 
to metHb. The oxyHb and metHb difference spectrum was calculated and plotted against 
the wavelengths. As shown in Fig. 4 the highest positive and negative differences were 
observed at 401.5 nm and 423.4 nm. These peaks, isosbestic points and the highest and 
lowest absorbance difference were similar to the values reported by other investigators 
(Feelisch 1996; Ghafourifar 2005). To measure NO formation produced by mtNOS, we 
used 401-420 nm with ε401-420 (metHb-oxyHb) 100 mM-1 cm-1 (Ghafourifar 2005; Feelisch 
1996) that provides sensitive measurements when dual wavelength spectroscopy is used. 
 
mtNOS activity: 
Fig. 5 shows that Ca2+ causes an increase in mtNOS-derived NO formation in a manner 
inhibited with L-NMMA that indicated mtNOS is Ca2+-sensitive and confirms previous 
reports by other investigators (Ghafourifar 1997; Ghafourifar 1999e; Arnaiz 1999; 
Manzo-Avalos 2002; Boveris 2003; Dedkova 2003 and Alvarez 2003). 
 
Tam and mtNOS activity: 
Therapeutic concentrations of Tam (0.1 and 0.3 µM) increased mtNOS activity of broken 
rat liver mitochondria in an L-NMMA-sensitive manner (Fig. 6). The data presented here 
was statistically significant (P≤0.01). These results indicate that Tam stimulates mtNOS 
activity and suggest that mtNOS may contribute to the Tam-induced increase in NOS 
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activity reported by several other investigators (Loo 1998; Maccarone 1998; Figtree 
2000). 
 
 
Tam increases [Ca2+]m 
In previous studies performed in our laboratory, it has been shown that Tam increases 
mtNOS activity by increasing [Ca2+]m using various approaches including spectroscopy 
(Arsenazo III a Ca2+- sensitive probe) and a Ca2+- sensitive electrode. These studies have 
detected the [Ca2+]m when it was released from the mitochondria into the extra 
mitochondria. In the present study, we used Fura-2/AM and studied [Ca2+]m while it was 
within the mitochondria. 
 
Fura-2 peak and isosbestic point: 
Fluorometry was used in order to measure [Ca2+]m. To find peak and isosbestic points, the 
fluorescent Ca2+ probe Fura-2 active form (10 µM) was excited from 320 to 400 nm. The 
spectra shown in Fig. 7 shows the peak at 352 nm and isosbestic point at 362 nm. The 
peak showed a dose dependent increase in fluorescence when mitochondria were loaded 
with 1, 3, or 10 µM Ca2+ and that fluorescences reaches saturation when mitochondria 
were loaded with 30 µM Ca2+. Collectively, these data suggest indicates that Fura-2 can 
be used as a fluorescent Ca2+- sensitive probe and the wavelengths 352 and 362 nm of 
peak and isosbestic points, respectively can be used for the measured of [Ca2+]m.  
Further study was conducted to test whether the same peak and isosbestic 
points can be observed in intact mitochondria. Intact rat liver mitochondria were 
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incubated with the membrane permeable Fura-2/AM. In mitochondria, Fura-2/AM is 
cleaved by esterases to the membrane impermeable Fura-2 which is an active Ca2+-
sensitive fluorescent probe (Zottini 1993; Zaidan 1994), and can detect the [Ca2+]m. When 
Fura-2/AM loaded intact rat liver mitochondria were excited from 320 to 400 nm, the 
same fluorescence peak and isosbestic points were observed at 352 and 362 nm, 
respectively (Fig. 8). Also, the peak showed a dose dependent increase in fluorescence 
when mitochondria were loaded with 1, 3, 10 or 30 µM Ca2+ and saturated when 100 µM 
Ca2+ was added. Taken together, findings indicate that this assay can be used to measure 
[Ca2+]m inside the mitochondria. 
Next, studies were conducted to test whether the observed peak and 
isosbestic points could be used to detect an increase in [Ca2+]m in intact mitochondria.  
When Fura-2/AM loaded rat liver mitochondria were excited at 352-362 nm, a dose-
dependent increase in fluorescence was detected when these mitochondria were loaded 
with 1, 3 or 10 µM Ca2+ and saturated with 30 µM Ca2+ (Fig. 9). When [Ca2+]m was 
chelated by EGTA (5mM) a drastic drop in the fluorescent signal was observed. Thus, 
these experiments indicate that wavelengths 352-362 nm can be used to detect [Ca2+]m 
inside intact mitochondria. 
 
∆ψ: 
Accumulation of cations such as Ca2+ within mitochondrial matrix can neutralize the 
negative charges of the inner mitochondrial membrane and decrease the ∆ψ. This would 
interfere with our measurements of [Ca2+]m, since a decreased ∆ψ would allow [Ca2+]m 
efflux.  Fig. 10 shows that intact mitochondria energized with succ (300 µM) maintain 
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the ∆ψ also when [Ca2+]m was elevated by loading mitochondria with Ca2+ (10 µM). This 
indicates that succ used in (see in Tam and [Ca2+]m) is sufficient to maintain the ∆ψ. 
 
Tam and [Ca2+]m: 
We studied whether Tam increases the [Ca2+]m in intact mitochondria. When Fura-2/AM 
loaded mitochondria were treated with Tam (Tam 0.1 and 0.3 µM) and excited at 352-
362 nm, a clear increase in fluorescence was detected indicating an increase in [Ca2+]m 
(Fig. 11). To verify the signal and to provide a scale, these mitochondria were loaded 
with Ca2+ (10 µM). An increase in fluorescence was observed that also provided a scale 
for quantification. At the end of the test, ∆ψ was collapsed by FCCP (5 µM) which 
uncouples the mitochondria (Fig. 12), this validates the assay. This indicates that the 
observed increase in [Ca2+]m induced by Tam was, indeed, measured inside the intact 
mitochondria.  
Mitochondria take up and accommodate large amounts of calcium very 
rapidly; however, the [Ca2+]m is maintained very low by several mechanisms including 
precipitation of Ca2+ to form mitochondrial matrix electron-dense granules (Ashraf 1976; 
Karcsu 1983; Pozzan 1994; Pozzan 2000). The amount and content of these granules vary 
in different physiological and pathological conditions (Ashraf 1976; Karcsu 1983; 
Rousou 2004; Carafoli 1987). Earlier reports have suggested that rat liver and heart 
mitochondria contain 1-2 nmol Ca2+ per mg mitochondrial protein (Carafoli 1987). 
Considering 7.2 x 109 mitochondria in each mg mitochondrial protein and a volume of 
7.1 µm3 for each mitochondrion (Loud 1968), the [Ca2+]m can be estimated as 2-4 µM. 
Recent studies have detected lower [Ca2+]m, e.g., around 100 nM in heart mitochondria 
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(Sheu 1999; Miyata 1991). Mitochondria maintain a dynamic intraorganelle Ca2+ 
homeostasis, i.e., Ca2+ constantly precipitates to the matrix electron-dense granules and 
releases from the granules (Loud 1968; Carafoli 2002; Tyler 1992). Several drugs, 
hormones, or pathologic conditions alter intramitochondrial calcium homeostasis. For 
example, vasopressin decreases the matrix electron-dense granules in the mitochondria of 
secretory neurons (Karesu 1983). In rat liver mitochondria, anoxia decreases the [Ca2+]m 
(Chang 2002) and in heart mitochondria electron-dense calcium granules are formed 
during ischemia (Ashraf 1976, Rousou 2004). Findings presented in the present study 
suggest that Tam increases the [Ca2+]m by shifting the ionized/non-ionized mitochondrial 
calcium in the favor of ionized Ca2+ (Scheme I). These findings may point to a novel 
mechanism for the action of widely used anti-breast cancer drug, Tam. 
 
Tam and ∆ψ 
The ∆ψ renders the inside of the mitochondrial inner membrane negative. Accumulation 
of cations such as Ca2+ within mitochondrial matrix can neutralize the negative charges 
of the inner mitochondrial membrane and decrease the ∆ψ. Fig. 13 shows that Tam (Tam 
0.1) decreased the ∆ψ in a manner prevented when [Ca2+]m was chelated by EGTA, 
which provides further evidence that Tam increases the [Ca2+]m. 
Taken together, the present study shows that Tam stimulates mtNOS 
activity by elevating [Ca2+]m (Scheme I). Tam decreases the ∆ψ due to an increase in the  
Ca2+ accumulated within mitochondrial matrix that counteracts the negative charges of 
the inner mitochondrial membrane. These findings suggest an alteration in 
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intramitochondrial Ca2+ homeostasis induced by Tam which in turn stimulates mtNOS 
activity, and proposes a novel mechanism for the cancer chemotherapeutic agent, Tam. 
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Figure 1. The absorption spectrum of Tam. Tam was dissolved in HEPES buffer (100 
mM pH 7.10) at room temperature. Peak at 275 nm was observed. 
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Figure 2. Absolute absorption spectrum of oxyHb. OxyHb was dissolved in HEPES 
buffer (100 mM pH 7.10) at room temperature. Peaks at 415.2, 541.8, and 577.6 nm were 
observed. 
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Figure 3. Aminco DW-2000 dual-beam dual-wavelengths spectrophotometer. A) The 
spectrophotometer. B) Aminco DW-2000 Original Fluorescent Accesory Unit equipped 
with a precision 510 ± 5 nm Bandpass Filter. C) A closer look to the bandpass filter 
attached to the spectrophotometer. 
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Figure 4. Oxy- and methemoglobin. The spectra of 10 µM oxyHb and metHb at 23 oC 
were recorded from 380 to 680 nm.  Peaks and isosbestic points are shown by solid and 
dashed arrows, respectively.  The inset shows the difference spectrum.  
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Figure 5. mtNOS activity determination. mtNOS activity of rat liver broken mitochondria 
was determined at using oxyHb assay.  Buffer (100 mM Hepes pH 7.10) was added to the 
cuvette and after reaching a steady reading oxyHb was added (4 µM; arrow head).  1) 
autoxidation of oxyHb in the absence of broken mitochondria; 2) Same as trace 1, but rat 
liver broken mitochondria (0.03 mg / ml) were present in the buffer prior to the addition 
of oxyHb; 3) same as traces 2, while mtNOS activity was stimulated by Ca2+ (100 µM); 
4) Same as panel C, with the addition of L-NMMA (100 µM). 
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Figure 6. Tam and mtNOS activity. Broken mitochondria treated with (■) Tam (Tam 0.1 
and 0.3 µM) or (□) ethanol (Cont) in presence or absence of L-NMMA (stripped) and 
mtNOS activity was determined using oxyHb assay. 
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Figure 7. Determination of Fura-2 peak and isosbestic points. Fura-2 (the active form; 10 
µM) in the absence (no Ca2+) or presence of 1, 3, 10, 30 µM Ca2+ was excited at 320 to 
400 nm and the emission was recorded at 510 nm.  
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Figure 8. Determination of Fura-2 peak and isosbestic points in intact mitochondria. 
Fura-2/AM loaded intact mitochondria in the absence (no Ca2+) or presence of 1, 3, 10, 
30, 100 µM Ca2+ was excited at 320 to 400 nm and the emission was recorded at 510 nm. 
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Figure 9. Using the detected peak and isosbestic points in intact mitochondria. Fura-
2/AM loaded mitochondria were excited at 352-362 nm and the emission was recorded at
510 nm.  These mitochondria were loaded with increasing concentrations of Ca2+ (arrow
heads; shown as µM Ca2+).  EGTA was added to validate the assay.
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Figure 10. Maintaining the ∆ψ.  Mitochondria were energized with succ in the presence 
of rotenone and Ca2+ (10 µM) was added where indicated. The ∆ψ was measured by 
dual-wavelengths spectroscopy at 511 – 533 nm using safranin (10 µM) as described 
(Ghafourifar 1999c). 
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Figure 11. Tam and [Ca2+]m. Fura-2/AM loaded intact mitochondria (2 mg) in a final 
volume of 2 ml HEPES buffer (100 mM pH 7.10) containing EGTA (50 µM) were used 
to study the effect of Tam (Tam 0.1 and 0.3 µM) or ethanol (Cont) on [Ca2+]m. These 
mitochondria were excited at 352-362 nm and the emission was recorded at 510 nm. 
Trend lines were used to show the data.  
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Figure 12. Validation of Tam and [Ca2+]m Fura-2 assay. The Fura-2/AM mitochondria 
incubated with Tam were energized with succinate (succ; 300 µM). After 4 min run of 
Tam, Ca2+ (10 µM) was added to provide scale for quantification. At the end of the test 
∆ψ was collapsed by an uncoupler carbonylcyanide-4-trifluoromethoxyphenylhydrazone 
(FCCP; 5 µM) to validate the assay.  
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Figure 13. Tam and ∆ψ. The ∆ψ of mitochondria (0.6 mg/ml) treated with 0.1 µM Tam 
(Tam 0.1) or its solvent (Cont) was supported by 0.8 mM succinate (succ) and measured 
at 511 – 533 nm. At the end of the test ∆ψ was collapsed by uncoupling mitochondria 
with carbonyl cyanide m-chlorophenylhydrazone (CCCP; 1 µM). Where indicated, 5 mM 
EGTA (Tam 0.1 + EGTA) was present in the buffer. 
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Scheme I. Mitochondria, mtNOS and Tamoxifen.
Mitochondria consist of the inner (IM) and the outer membrane (OM), matrix, and the
intermembrane space (IMS).  The respiratory chain consists of four complexes (I to IV),
coenzyme Q (ubiquinone; Q), and ATP synthase also called complex V, which are
embedded in the IM.  Electrons (e-) flow down the chain to complex IV and reduce O2 to
H2O.  Coupled to the electron flow, protons (H+) are pumped from the matrix into the
IMS.  The IM is impermeable to H+ and protons can re-enter the matrix through the ATP
synthase machinery.  This proton extrusion establishes a transmembrane potential Δψ;
negative inside) and an electrochemical gradient (ΔpH; alkaline inside) across the
coupling membrane.  The Δψ is the driving force for mitochondria to take up Ca2+.
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Although mitochondria can take up relatively large quantities of Ca2+, intramitochondrial
ionized Ca2+ concentration ([Ca2+]m) is maintained very low by several mechanisms
including precipitation of the [Ca2+]m to form non-ionized calcium pools, the matrix
electron-dense granules.
Mitochondria generate Nitric oxide (NO) through mitochondrial NO synthase
(mtNOS).  mtNOS is Ca2+-sensitive and elevation of [Ca2+]m increases the mtNOS
activity.  mtNOS-derived NO reversibly inhibits mitochondrial respiration by competing
with O2 for the O2 binding site on complex IV.  mtNOS-derived NO also reacts with
superoxide anion (O2-), generated by the respiratory chain complexes, to produce
peroxynitrite (ONOO-), that induces cytochrome c (cyto c) release, elevates lipid
peroxidation (LPO) and nitrates tyrosine residues of susceptible proteins including
succinyl-CoA:3-oxoacid CoA-transferase (SCOT).
The present study suggests that Tamoxifen (Tam) shifts the mitochondrial non-
ionized / ionized calcium equilibrium in the favor of the ionized form.  Elevated [Ca2+]m
stimulates mtNOS activity that increases intramitochondrial ONOO- that induces
oxidative stress and mitochondrial apoptosis.
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CHAPTER V
Summary and Conclusion
Summary
Breast cancer is a second major cause of death due to cancer in women. Tamoxifen
(Tam) is a well-known estrogen receptor (ER) antagonist widely used in the treatment of
breast cancer. However, it has been shown that Tam induces programmed cell death, or
apoptosis, in both ER positive and ER negative cells with mechanisms that are not fully
understood. Mitochondria play a key role in apoptosis. Suppressed mitochondrial
functions, release of mitochondrial apoptogenic proteins, and elevated oxidative and
nitrative stress are commonly observed in apoptosis induced by a variety of apoptosis
stimuli, including nitric oxide (NO). Recently, the presence of a nitric oxide synthase
(NOS) in mitochondria (mitochondria NOS; mtNOS) and its pivotal role in regulating
mitochondrial functions was reported. Stimulation of mtNOS suppresses mitochondrial
functions, releases apoptogenic proteins from mitochondria, and induces oxidative stress.
Tam-induced apoptosis occurs in a NOS- and mitochondria-dependent manner along with
suppressed mitochondrial functions and oxidative stress. The hypothesis for the present
study was to test the effect of therapeutic concentration of Tam on mtNOS activity.
To test the effect of Tam on mtNOS activity oxyhemoglobin (oxyHb)
assay was used.  It was found that therapeutic concentrations of Tam increased mtNOS
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activity of broken rat liver mitochondria in an L-NMMA-sensitive manner. These
findings indicate that Tam stimulates mtNOS activity.
The mtNOS is Ca2+-sensitive i.e., elevation of intramitochondrial
concentration [Ca2+]m increases the activity of mtNOS. Thus, we tested the effect of Tam
on [Ca2+]m. This was measured by fluorometery using the fluorescent Ca2+ probe, Fura-2.
It was found that therapeutic concentrations of Tam increase the [Ca2+]m which can serve
as the mechanism by which Tam stimulates mtNOS.
Increased [Ca2+]m can neutralize the negative charges of the inner
mitochondrial membrane the Δψ. Thus we tested the effect of Tam on Δψ. It was found
that therapeutic concentrations of Tam decreased the Δψ in a manner prevented when
[Ca2+]m was chelated.
Altogether, present study shows that Tam stimulate mtNOS activity by
increasing [Ca2+]m. Tam decreases the Δψ due to increase in the Ca2+ accumulated within
mitochondrial matrix. These findings suggest an alteration in intramitochondrial Ca2+
homeostasis induced by Tam which in turn stimulates mtNOS activity, and propose a
novel mechanism for the anti-breast cancer drug, Tam.
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Conclusion
The NO formation by mtNOS was increased by Tamoxifen (Tam).
The intramitochondrial concentration of Ca2+ ([Ca2+]m) was elevated by Tam.
Tam also decreased the transmembrane potential Δψ.
These findings suggest a novel mechanism for Tam.
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